These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11575181)

  • 1. [How can we protect against broad-band pathogens? The situation with quinolone resistance].
    Kresken M; Hafner D
    Pharm Unserer Zeit; 2001; 30(5):436-45. PubMed ID: 11575181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial internalization and intracellular activity of quinolones and macrolides].
    Bellussi L; De Benedetto M; Lauriello M; Passali GC; Passali D
    Acta Otorhinolaryngol Ital; 2007 Apr; 27(2 Suppl 87):1-11. PubMed ID: 17702375
    [No Abstract]   [Full Text] [Related]  

  • 3. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of in vitro data with newer quinolones.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):662-3. PubMed ID: 16312581
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of resistance in infectious agents of agricultural animals in Germany (1990-1994)--a review].
    Trolldenier H
    Dtsch Tierarztl Wochenschr; 1996 Jul; 103(7):256-60. PubMed ID: 8998938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of patients with resistant bacterial infections.
    Rahal JJ
    Bull N Y Acad Med; 1987 Apr; 63(3):318-29. PubMed ID: 3300830
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action and reaction. Actions and resistance mechanisms of quinolone].
    Heisig P; Wiedemann B
    Pharm Unserer Zeit; 2001; 30(5):382-93. PubMed ID: 11575174
    [No Abstract]   [Full Text] [Related]  

  • 13. First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.
    Liassine N; Zulueta-Rodriguez P; Corbel C; Lascols C; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 Nov; 62(5):1151-2. PubMed ID: 18669519
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmid-mediated quinolone resistance--current knowledge and future perspectives.
    Guan X; Xue X; Liu Y; Wang J; Wang Y; Wang J; Wang K; Jiang H; Zhang L; Yang B; Wang N; Pan L
    J Int Med Res; 2013 Feb; 41(1):20-30. PubMed ID: 23569126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 16. [The problem and current situation of drug-resistant bacteria in medical settings].
    Matsumoto T
    Rinsho Byori; 2012 Oct; 60(10):955-8. PubMed ID: 23323459
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of antibacterial resistance.
    Hickey SM; Nelson JD
    Adv Pediatr; 1997; 44():1-41. PubMed ID: 9265966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possible development of resistance to quinolones. Its significance for general practice].
    Mohr CP
    Fortschr Med; 1988 Mar; 106(9):181-4. PubMed ID: 3286434
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.